Perspective Insights to Bio-Nanomaterials for the Treatment of Neurological Disorders
Open Access
- 12 October 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9
Abstract
The significance of biomaterials is well appreciated in nanotechnology, and its use has resulted in major advances in biomedical sciences. Although, currently, very little data is available on the clinical trial studies for treatment of neurological conditions, numerous promising advancements have been reported in drug delivery and regenerative therapies which can be applied in clinical practice. Among the commonly reported biomaterials in literature, the self-assembling peptides and hydrogels have been recognized as the most potential candidate for treatment of common neurological conditions such as Alzheimer’s, Parkinson’s, spinal cord injury, stroke and tumors. The hydrogels, specifically, offer advantages like flexibility and porosity, and mimics the properties of the extracellular matrix of the central nervous system. These factors make them an ideal scaffold for drug delivery through the blood-brain barrier and tissue regeneration (using stem cells). Thus, the use of biomaterials as suitable matrix for therapeutic purposes has emerged as a promising area of neurosciences. In this review, we describe the application of biomaterials, and the current advances, in treatment of statistically common neurological disorders.Keywords
This publication has 103 references indexed in Scilit:
- Nanomaterials in Stroke TreatmentStroke, 2013
- Neurological disorders and therapeutics targeted to surmount the blood–brain barrierInternational Journal of Nanomedicine, 2012
- Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cellsNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehiclesBiomaterials, 2011
- Tuning β-Sheet Peptide Self-Assembly and Hydrogelation Behavior by Modification of Sequence Hydrophobicity and AromaticityBiomacromolecules, 2011
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System InfectionsClinical Microbiology Reviews, 2010
- β-hairpin-forming peptides; models of early stages of protein foldingBiophysical Chemistry, 2010
- The Science of Stroke: Mechanisms in Search of TreatmentsNeuron, 2010
- Biomaterials for the central nervous systemJournal of The Royal Society Interface, 2008